ArticlePloS one2026
Characterization of mesenchymal stromal cell-mediated mitochondrial transfer to healthy and diseased intervertebral disc cells.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Intradiscal injection of mesenchymal stromal cells has gained widespread interest for the treatment of intervertebral disc degeneration. Mesenchymal stromal cells have been shown to impart a therapeutic benefit on treated tissues through a variety of mechanisms including mitochondrial transfer. Mitochondrial transfer from mesenchymal stromal cells to diseased cells has been demonstrated, in numerous model systems, to increase the survival and function of recipient cells. To date there are few studies that have investigated mitochondrial transfer from mesenchymal stromal cells to intervertebral disc cells. The goal of this study is to characterize mitochondrial transfer from mesenchymal stromal cells to bovine and human intervertebral disc cells using confocal microscopy. Following a 24-hour coculture period, bovine mesenchymal stromal cells were shown to transfer mitochondria to bovine annulus fibrosus cells under both healthy and inflammatory conditions. In addition, human mesenchymal stromal cells were shown to transfer mitochondria to diseased, patient-derived intervertebral disc cells. Mitochondrial transfer quantity was found to increase under inflammatory stress conditions and with patient age, though functional consequences of this transfer remain to be determined. This study is the first to show mesenchymal stromal cells transfer mitochondria to bovine annulus fibrosus cells and patient derived intervertebral disc cells. We provide evidence that mitochondrial transfer is a relevant mechanism by which mesenchymal stromal cells communicate with intervertebral disc cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.